Cleared Traditional

K062652 - INNERSCAN BODY COMPOSITION MONITOR, INNERSCAN SEGMENTAL BODY COMPOSITION MONITOR

K062652 is an FDA 510(k) clearance for INNERSCAN BODY COMPOSITION MONITOR, manufactured by Tanita Corporation of America. The device is a Class 2 Gastroenterology & Urology device with product code MNW cleared through the Traditional 510(k) pathway after a 112-day FDA review.

K062652 · Tanita Corporation of America · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2006
Decision
112d
Days
Class 2
Risk

K062652 is an FDA 510(k) clearance for the INNERSCAN BODY COMPOSITION MONITOR, INNERSCAN SEGMENTAL BODY COMPOSITION MONITOR. Classified as Analyzer, Body Composition (product code MNW), Class II - Special Controls.

Submitted by Tanita Corporation of America (Arlington Heights, US). The FDA issued a Cleared decision on December 28, 2006 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 870.2770 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Tanita Corporation of America devices

FDA 510(k) Submission Details - K062652

510(k) Number K062652 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 07, 2006
Decision Date December 28, 2006
Days to Decision 112 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d faster than avg
Panel avg: 131d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MNW Device Classification - Class 2, Special Controls

Product Code MNW Analyzer, Body Composition
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - MNW Analyzer, Body Composition

All 65
Devices cleared under the same product code (MNW) and FDA review panel - the closest regulatory comparables to K062652.
BODY COMPOSITION ANALYZER, MODELS: X-SCAN PLUS II, GAIA 359 PLUS, PLUSAVIS 333, XBIA 500, XBIA 900
K071884 · Jawon Medical Co., Ltd. · Aug 2007
BC (BODY COMPOSITION SOFTWARE)
K070999 · Rjl Systems, Inc. · Aug 2007
BIOSPACE BODY COMPOSITION ANALYZERS, MODEL INBODY 230
K062603 · Biospace Corporation Limited · Feb 2007
BODY COMPOSITION MONITOR WITH SCALE, MODEL HBF-500
K062043 · Omron Healthcare, Inc. · Nov 2006
BEAVERITE BODY FAT SCALES, MODELS 8901, 8903, 8905, 8909, 8911, 8915, 9563 AND 9568
K060538 · Beaverite International Limited · Oct 2006
BODY COMPOSITION ANALYZER, MODELS ZEUS 9.9 AND VENUS 5.5
K053556 · Jawon Medical Co., Ltd. · Aug 2006